Wuyi Cihang Pharmaceutical

Wuyi Cihang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturing company founded in 2000 and based in Wuyi County, Hebei Province. The company is recognized as a high-tech small and medium-sized enterprise specialized in the production of Active Pharmaceutical Ingredients (APIs) and chemical raw materials. Its commercial portfolio includes antipyretic, analgesic, and lipid-lowering agents such as benorilate, probucol, and olopatadine hydrochloride. In addition to its established products, Wuyi Cihang maintains a research focus on the synthesis of advanced generic small molecule therapies, including finerenone, sivelestat sodium, and baricitinib. The company serves as a key supplier within the global pharmaceutical supply chain, frequently exhibiting its manufacturing capabilities at major international trade platforms like CPHI China. Through its focus on quality synthesis and broad therapeutic coverage, Wuyi Cihang supports markets in cardiovascular, respiratory, and inflammatory health.